PFS was defined as the time from first infusion of CAR-T cells to progression of disease (CNS or Systemic) or death. Duration of remission (DOR) was defined as time from CR/PR to relapse or death without documented relapse. OS was defined as the time from first infusion of CAR-T cells to the date of death. The Clopper-Pearson 95% confidence interval (CI) and Fisher’s Exact test were used to analyze the classification variables. Kaplan-Meier methodology was used to estimate the medians for PFS and OS survival. Log-rank test was used to compared the survival of different groups. Follow-up periods were calculated using the reverse Kaplan-Meier method. SPSS 25 statistical analysis software was used for analysis, and p value less than 0.05 was considered as significant difference.
Spss 25 statistical analysis software
Manufactured by IBM
Sourced in United States
SPSS 25 is a statistical analysis software developed by IBM. It provides a comprehensive set of tools for data management, analysis, and reporting. The software offers a wide range of statistical techniques, including descriptive statistics, regression analysis, and advanced statistical modeling. SPSS 25 is designed to help users analyze data, identify trends, and make informed decisions.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using spss 25 statistical analysis software
1
Evaluating CAR-T Cell Therapy Outcomes
2
Comparative Analysis of Experimental Treatments
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
All data are expressed as mean ± standard error of mean (n = 4–5/group). The means of different groups were analyzed using one-way analysis of variance analysis of variance with Bonferroni corrections or Mann-Whitney U testing (nonparametric) based on the homogeneity of variance testing (Levene’s test) using SPSS 25 statistical analysis software (SPSS Inc., Chicago, IL, USA). The differences were considered significant at P < 0.05.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!